Real-time enrollment status for this metastatic cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:10 PM UTC
| NCT Number | NCT04295863 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Cancer |
| Phase | PHASE1 |
| Target Enrollment | 264 participants |
| Active Locations | 2 sites in the US |
| Sponsor | University of Chicago |
| Last Updated on CT.gov | October 1, 2025 (Oct 1, 2025) |
As of July 17, 2026: Clinical trial NCT04295863 is currently recruiting participants. This phase1 study for metastatic cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by University of Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04295863 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04295863 was last updated Oct 1, 2025 (October 1, 2025). HelloStudys verifies this status automatically.